Is pharmacokinetic profile of talipexole in healthy volunteers altered when it is co-administered with Madopar ( co-beneldopa )?
A single oral dose of Madopar co-administered with talipexole does not significantly change talipexole's pharmacokinetics in human.
The previous AJCC rules for the T4 tumors were a better indicator of poor prognosis.